SCHEMBL4355245

SCHEMBL4355245

CN(C)C1(C(NC(=O)c2cccc3cc(Cl)ccc23)c2ccccc2)CCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SLC6A9 P48067 6/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
CTSV O60911 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
RAB9A P51151 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TACR3 P29371 2/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3244199 0.84 MEN1 (0.49) MEN1KMT2ASLC6A9ALDH1A1CTSL
SCHEMBL3237602 0.84 GPR139 (0.50) MEN1KMT2ASLC6A9ALDH1A1CYP3A4
SCHEMBL3239983 0.83 UTS2R (0.42) MEN1KMT2ASLC6A9ALDH1A1CYP3A4
SCHEMBL3239515 0.82 KCNA3 (0.44) MEN1KMT2ASLC6A9CYP3A4CYP2D6
SCHEMBL3240657 0.82 TACR3 (0.43) SLC6A9CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL3238239 0.81 CHRM1 (0.42) MEN1KMT2ASLC6A9CYP3A4CYP2D6
SCHEMBL3244891 0.81 SLC6A9 (0.59) SLC6A9
SCHEMBL3237145 0.80 AVPR2 (0.43) MEN1KMT2ASLC6A9ALDH1A1LMNA
SCHEMBL3237802 0.80 SLC6A9 (0.48) MEN1KMT2ASLC6A9LMNARAB9A
SCHEMBL3230692 0.80 SLC6A9 (0.48) SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286828-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES GLAXO GROUP LIMITED (GB) 2009-11-19 US disclosed
US-20090286828-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES GLAXO GROUP LIMITED (GB) 2009-11-19 US disclosed
US-20090286828-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES GLAXO GROUP LIMITED (GB) 2009-11-19 US disclosed
WO-2006067430-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES GLAXO GROUP LIMITED (GB) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286828-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES PNMT, SLC18A2, COMT MEN1 3151/4885KMT2A 112/4885SLC6A9 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.